|
Using Wearable Technology to Develop Biomarker-Driven Intervention for Alcohol-Facilitated Intimate Partner Violence |
1R21AA029235-01A1 |
|
NIAAA |
2022 |
|
Impact of Prenatal alcohol on Alzheimers disease related pathology and cognitive impairment |
1R21AA029263-01A1 |
|
NIAAA |
2022 |
|
The role of mitochondrial stress response in alcohol-mediated neurotoxicity |
1R21AA029811-01A1 |
|
NIAAA |
2022 |
|
Discreet Wearable device for Continuous Real-time Monitoring of Alcohol |
1R44AA030231-01A1 |
|
NIAAA |
2022 |
|
Adapting and testing a behavioral intervention to prevent FASD and adverse infant outcomes |
1R61AA030043-01 |
|
NIAAA |
2022 |
|
tDCS and cognitive training as a neurodevelopmental intervention in FASD |
1U01AA030164-01 |
|
NIAAA |
2022 |
|
Cardiovascular disease in fetal alcohol spectrum disorder |
1U01AA030185-01 |
|
NIAAA |
2022 |
|
Designing a Hybrid Intervention Strategy to Reduce Alcohol Exposed Pregnancies. |
1U01AA030187-01 |
|
NIAAA |
2022 |
|
Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD) Data Coordination Resource |
1U24AA030169-01 |
|
NIAAA |
2022 |
|
Project 2: Prenatal Alcohol Exposure (PAE) and Fetal Alcohol Spectrum Disorder (FASD) |
1U54AA030451-01 |
|
NIAAA |
2022 |